Back to search

A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung
Clinicaltrials.gov:
Other:
#61186372PANSC2004
Interested in this trial?
Subscribe or share this trial
Countries:
  • Canada,
  • China,
  • South Korea,
  • Turkey (Türkiye),
  • United States
Loading...
Enrolling
Çankaya, Turkey (Türkiye), 06800
Enrolling
Ankara, Turkey (Türkiye), 06620
Enrolling
Seoul, South Korea, 05505
Enrolling
Istanbul, Turkey (Türkiye), 34010
Enrolling
New York, New York, United States, 10016
Enrolling
Toronto, Ontario, Canada, M5G 2M9
Enrolling
Seoul, South Korea, 06351
Enrolling
Seoul, South Korea, 03722
Enrolling
Shanghai, China, 310000
Enrolling
Guangzhou, China, 510060
Enrolling
Fairfax, Virginia, United States, 22031
Currently on Hold
Puyallup, Washington, United States, 98373
Currently on Hold
Houston, Texas, United States, 77030
Currently on Hold
Irvine, California, United States, 92697
Currently on Hold
Philadelphia, Pennsylvania, United States, 19104
#
More than 50 sites in this region
#
More than 10 sites in this region
#
Less than 10 sites in this region
Map pin icon representing individual study sites
Individual sites
Access detailed information on the trial:
© Johnson & Johnson and its affiliates 2026
J&J Clinical Trials